What I really liked about yesterdays interview was that I got the impression that NP was factually telling Pfizer that whatever they would do regarding Maraviroc Cydy would follow (suit) making use of Pfizers findings because of the same MOA.
That must be really frustrating for Pfizer. Enough to take out this nuisance? Maybe.